LONDON, March 22 (Reuters) - A two-in-one prostate drug from GlaxoSmithKline has won approval in Switzerland, its first European market, the British-based drugmaker said on Monday. Sign up here.

GlaxoSmithKline (GSK) announced today that the Swiss regulatory authority, Swissmedic, has granted approval for Duodart®, a fixed dose combination (FDC) of dutasteride (0.5mg) and tamsulosin (0.4mg).

LONDON, March 31 (Reuters) - Duodart, a two-in-one prostrate drug from GlaxoSmithKline , has been approved in Europe, the British drugmaker said on Wednesday. Sign up here. The backing -- from Germany ...